EUVIMEDEUVIMED entdecken
Crossref

Rapidly Liver-Accumulating BiOCl@ITA Nanozyme for Synergistic ROS Scavenging and Macrophage Reprogramming in APAP-Induced Liver Injury

Junli Huang iD, Huan Huang, Ke Huang, Baomin Fang, Xueying Bi, Shitong Huang, Henghai Su, Jiacheng Li

ACS Applied Materials & Interfaces · 2026

DOI: 10.1021/acsami.6c08667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Junli Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi530021, Chin…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Acetaminophen, Macrophages, Bismuth. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, Guangzhou Municipal Science and Technology Project, Guangzhou Municipal Health and Family Planning Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP) overdose is the leading cause of acute liver failure worldwide, yet existing therapy relies solely on N-acetylcysteine (NAC), whose efficacy diminishes markedly beyond an 8−10 h therapeutic window. The underlying pathology involves a self-amplifying cycle of reactive oxygen species (ROS) overproduction and macrophage-mediated inflammation, and strategies that concurrently scavenge ROS, reprogram macrophage polarization, and attenuate hepatocyte apoptosis remain lacking. Itaconate (ITA), an endogenous anti-inflammatory metabolite, suffers from poor membrane permeability and lacks intrinsic ROS-scavenging capacity. Herein, we constructed BiOCl@ITA by integrating defect-engineered bismuth oxychloride (BiOCl) with surface-loaded ITA. Oxygen vacancy engineering confers intrinsic superoxide dismutase (SOD)- and catalase (CAT)-mimicking activities under stimulus-free conditions. BiOCl@ITA showed rapid accumulation in the liver within 0.5 h after intraperitoneal administration and was efficiently internalized by both hepatocytes and macrophages in vitro. Moreover, BiOCl@ITA virtually eliminated intracellular ROS and attenuated APAP-induced hepatocyte injury, while also reprogramming LPS-stimulated macrophages from M1 toward an M2 phenotype, consistently outperforming free ITA across all endpoints. In a murine APAP-induced ALI model, BiOCl@ITA-treated mice showed near-complete thermal recovery by 24 h, accompanied by substantially reduced serum hepatic injury markers and attenuated histopathological damage. Hepatic molecular and tissue-level analyses further demonstrated restoration of antioxidant defenses, favorable regulation of BAX/BCL-2 expression, and sustained M1-to-M2 macrophage polarization in vivo. These findings demonstrate that BiOCl@ITA synergistically integrates catalytic ROS detoxification with ITA-mediated macrophage reprogramming, offering a promising therapeutic approach for APAP-induced acute liver injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reactive Oxygen SpeciesAcetaminophenMacrophagesBismuthChemical and Drug Induced Liver InjurySuccinatesAnimalsMiceMaleLiverMice, Inbred C57BLHepatocytesRAW 264.7 Cells

Stichwörter der Autor:innen

ROS scavengingacute liver injurybismuth oxychlorideitaconatenanozymeoxygen vacancy engineering

Substanzen

Reactive Oxygen SpeciesAcetaminophenBismuthSuccinatesitaconic acid

Autor:innen und Institutionen

  • Department of pharmacy, The People's Hospital of Guangxi Zhuang Autonomous Region & Guangxi Academy of Medical Sciences, Nanning, Guangxi530021, China.
  • Department of Ophthalmology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou510180, China.
  • Guangxi Academy of Sciences , Nanning, Guangxi530007, China.

ORCID-Profile: Junli Huang

Förderung

  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • Guangzhou Municipal Science and Technology Project
  • Guangzhou Municipal Health and Family Planning Commission

Zitieren

APA

Huang, J., Huang, H., Huang, K., Fang, B., Bi, X., Huang, S., Su, H., & Li, J. (2026). Rapidly Liver-Accumulating BiOCl@ITA Nanozyme for Synergistic ROS Scavenging and Macrophage Reprogramming in APAP-Induced Liver Injury. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c08667

Vancouver

Huang J, Huang H, Huang K, Fang B, Bi X, Huang S, et al. Rapidly Liver-Accumulating BiOCl@ITA Nanozyme for Synergistic ROS Scavenging and Macrophage Reprogramming in APAP-Induced Liver Injury. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c08667

BibTeX
@article{Huang2026,
  author = {Huang, Junli and Huang, Huan and Huang, Ke and Fang, Baomin and Bi, Xueying and Huang, Shitong and Su, Henghai and Li, Jiacheng},
  title = {Rapidly Liver-Accumulating BiOCl@ITA Nanozyme for Synergistic ROS Scavenging and Macrophage Reprogramming in APAP-Induced Liver Injury},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c08667}
}
Kostenlos starten →